Israel Englander Protalix Bio Therapeutics, Inc. Transaction History
Millennium Management LLC
- $175 Billion
- Q1 2025
A detailed history of Israel Englander (Millennium Management LLC) transactions in Protalix Bio Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 963,011 shares of PLX stock, worth $1.4 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
963,011
Previous 387,921
148.25%
Holding current value
$1.4 Million
Previous $744,000
231.32%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding PLX
# of Institutions
70Shares Held
8.27MCall Options Held
227KPut Options Held
54.5K-
Jim Simons Renaissance Technologies LLC | New York, Ny1.19MShares$1.72 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA859KShares$1.25 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL685KShares$992,8990.0% of portfolio
-
Marshall Wace, LLP London, X0615KShares$891,8730.0% of portfolio
-
Connor, Clark & Lunn Investment Management Ltd.483KShares$700,1680.01% of portfolio
About Protalix BioTherapeutics, Inc.
- Ticker PLX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,753,400
- Market Cap $72.1M
- Description
- Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...